Soligenix, Inc. Repays and Terminates Loan Agreement with Pontifax Medison FinanceOn February 5, 2025, Soligenix, Inc. (NASDAQ:SNGX) announced in an SEC Filing the full repayment and termination of all outstanding obligations under the Loan and Secur
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Soligenix’s 8K filing here. Soligenix Company Profile (Get Free Report) Soligenix, Inc, a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. The company […]
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Soligenix’s 8K filing here. Soligenix Company Profile (Get Free Report) Soligenix, Inc, a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. The company […]
